Hysterectomy Device Market By Disease type (Uterine Cancer, Fibroids, Chronic pelvic pain, Others), By Surgical approach (Vaginal hysterectomy, Laparoscopic hysterectomy, Robotic assisted laparoscopic hysterectomy, Abdominal hysterectomy), By End User (Ho

Hysterectomy Device Market By Disease type (Uterine Cancer, Fibroids, Chronic pelvic pain, Others), By Surgical approach (Vaginal hysterectomy, Laparoscopic hysterectomy, Robotic assisted laparoscopic hysterectomy, Abdominal hysterectomy), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2022-2031


The global hysterectomy device market was valued at $328.09 million in 2021 and is projected to reach $566.5 million by 2031, registering a CAGR of 5.63% from 2022 to 2031.

The surgical removal of the uterus and, less frequently, the cervix is known as a hysterectomy. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the reason for the surgery. It is typically performed as a treatment for a variety of gynecological conditions, such as uterine fibroids, endometriosis, and abnormal uterine bleeding. Hysterectomy can be performed using a variety of surgical techniques, including open surgery, laparoscopic surgery, and robot-assisted surgery.

The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women’s health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.

However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy device market analysis from 2021 to 2031 to identify the prevailing hysterectomy device market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the hysterectomy device market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global hysterectomy device market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Surgical approach

Laparoscopic hysterectomy
Robotic assisted laparoscopic hysterectomy
Abdominal hysterectomy
Vaginal hysterectomy

By Disease type

Uterine Cancer
Fibroids
Chronic pelvic pain
Others

By End User

Hospitals
Ambulatory Surgical Centers
Others

By Region

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
B. Braun Melsungen AG
Conkin surgical instruments ltd
CONMED Corporation
Cooper Companies, Inc.
fortimedix surgical b.v.
Johnson & Johnson
KARL STORZ GmbH & Co. KG
Laborie, Inc
Medtronic plc
Richard Wolf GmbH

Please Note: It will take 7-10 business days to complete the report upon order confirmation.


CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate threat of substitutes
3.3.2. Moderate intensity of rivalry
3.3.3. High bargaining power of buyers
3.3.4. High bargaining power of suppliers
3.3.5. Moderate threat of new entrants
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of uterine cancer
3.4.1.2. Increase in awareness of women’s health
3.4.1.3. Technological advancements in hysterectomy devices
3.4.2. Restraints
3.4.2.1. Availability of alternative treatments
3.4.3. Opportunities
3.4.3.1. Increase in demand for the minimally invasive procedures
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Uterine Cancer
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Fibroids
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Chronic pelvic pain
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH
5.1. Overview
5.1.1. Market size and forecast
5.2. Vaginal hysterectomy
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Laparoscopic hysterectomy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Robotic assisted laparoscopic hysterectomy
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Abdominal hysterectomy
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: HYSTERECTOMY DEVICE MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ambulatory Surgical Centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: HYSTERECTOMY DEVICE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Disease type
7.2.3. Market size and forecast, by Surgical approach
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Disease type
7.2.5.1.3. Market size and forecast, by Surgical approach
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Disease type
7.2.5.2.3. Market size and forecast, by Surgical approach
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Disease type
7.2.5.3.3. Market size and forecast, by Surgical approach
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Disease type
7.3.3. Market size and forecast, by Surgical approach
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Disease type
7.3.5.1.3. Market size and forecast, by Surgical approach
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Disease type
7.3.5.2.3. Market size and forecast, by Surgical approach
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Disease type
7.3.5.3.3. Market size and forecast, by Surgical approach
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Disease type
7.3.5.4.3. Market size and forecast, by Surgical approach
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Disease type
7.3.5.5.3. Market size and forecast, by Surgical approach
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Disease type
7.3.5.6.3. Market size and forecast, by Surgical approach
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Disease type
7.4.3. Market size and forecast, by Surgical approach
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Disease type
7.4.5.1.3. Market size and forecast, by Surgical approach
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Disease type
7.4.5.2.3. Market size and forecast, by Surgical approach
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Disease type
7.4.5.3.3. Market size and forecast, by Surgical approach
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Disease type
7.4.5.4.3. Market size and forecast, by Surgical approach
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Disease type
7.4.5.5.3. Market size and forecast, by Surgical approach
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Disease type
7.4.5.6.3. Market size and forecast, by Surgical approach
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Disease type
7.5.3. Market size and forecast, by Surgical approach
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Disease type
7.5.5.1.3. Market size and forecast, by Surgical approach
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Disease type
7.5.5.2.3. Market size and forecast, by Surgical approach
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Disease type
7.5.5.3.3. Market size and forecast, by Surgical approach
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Disease type
7.5.5.4.3. Market size and forecast, by Surgical approach
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Conkin surgical instruments ltd
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. KARL STORZ GmbH & Co. KG
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. CONMED Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.4. Richard Wolf GmbH
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. fortimedix surgical b.v.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Johnson & Johnson
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.7. Laborie, Inc
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Cooper Companies, Inc.
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. B. Braun Melsungen AG
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. Medtronic plc
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
LIST OF TABLES
TABLE 01. GLOBAL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 02. HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY REGION, 2021-2031 ($MILLION)
TABLE 03. HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY REGION, 2021-2031 ($MILLION)
TABLE 04. HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY REGION, 2021-2031 ($MILLION)
TABLE 05. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. GLOBAL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 07. HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 09. HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 10. HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)
TABLE 11. GLOBAL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 12. HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. HYSTERECTOMY DEVICE MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. U.S. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 21. U.S. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 22. U.S. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 23. CANADA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 24. CANADA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 25. CANADA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 26. MEXICO HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 27. MEXICO HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 28. MEXICO HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 29. EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 30. EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 31. EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 32. EUROPE HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. GERMANY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 34. GERMANY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 35. GERMANY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 36. FRANCE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 37. FRANCE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 38. FRANCE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 39. UK HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 40. UK HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 41. UK HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 42. ITALY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 43. ITALY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 44. ITALY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 45. SPAIN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 46. SPAIN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 47. SPAIN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. JAPAN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 56. JAPAN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 57. JAPAN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 58. CHINA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 59. CHINA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 60. CHINA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. INDIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 62. INDIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 63. INDIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 64. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 65. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 66. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 68. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 69. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 74. LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 75. LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 76. LAMEA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 77. BRAZIL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 78. BRAZIL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 79. BRAZIL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 80. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 81. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 82. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 83. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 84. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 85. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 87. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)
TABLE 88. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 89. CONKIN SURGICAL INSTRUMENTS LTD: KEY EXECUTIVES
TABLE 90. CONKIN SURGICAL INSTRUMENTS LTD: COMPANY SNAPSHOT
TABLE 91. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT SEGMENTS
TABLE 92. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT PORTFOLIO
TABLE 93. KARL STORZ GMBH & CO. KG: KEY EXECUTIVES
TABLE 94. KARL STORZ GMBH & CO. KG: COMPANY SNAPSHOT
TABLE 95. KARL STORZ GMBH & CO. KG: PRODUCT SEGMENTS
TABLE 96. KARL STORZ GMBH & CO. KG: PRODUCT PORTFOLIO
TABLE 97. CONMED CORPORATION: KEY EXECUTIVES
TABLE 98. CONMED CORPORATION: COMPANY SNAPSHOT
TABLE 99. CONMED CORPORATION: PRODUCT SEGMENTS
TABLE 100. CONMED CORPORATION: PRODUCT PORTFOLIO
TABLE 101. RICHARD WOLF GMBH: KEY EXECUTIVES
TABLE 102. RICHARD WOLF GMBH: COMPANY SNAPSHOT
TABLE 103. RICHARD WOLF GMBH: PRODUCT SEGMENTS
TABLE 104. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
TABLE 105. FORTIMEDIX SURGICAL B.V.: KEY EXECUTIVES
TABLE 106. FORTIMEDIX SURGICAL B.V.: COMPANY SNAPSHOT
TABLE 107. FORTIMEDIX SURGICAL B.V.: PRODUCT SEGMENTS
TABLE 108. FORTIMEDIX SURGICAL B.V.: PRODUCT PORTFOLIO
TABLE 109. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 110. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 111. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 112. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 113. LABORIE, INC: KEY EXECUTIVES
TABLE 114. LABORIE, INC: COMPANY SNAPSHOT
TABLE 115. LABORIE, INC: PRODUCT SEGMENTS
TABLE 116. LABORIE, INC: PRODUCT PORTFOLIO
TABLE 117. COOPER COMPANIES, INC.: KEY EXECUTIVES
TABLE 118. COOPER COMPANIES, INC.: COMPANY SNAPSHOT
TABLE 119. COOPER COMPANIES, INC.: PRODUCT SEGMENTS
TABLE 120. COOPER COMPANIES, INC.: PRODUCT PORTFOLIO
TABLE 121. COOPER COMPANIES, INC.: KEY STRATERGIES
TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 124. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS
TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. HYSTERECTOMY DEVICE MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF HYSTERECTOMY DEVICE MARKET, 2021-2031
FIGURE 03. HYSTERECTOMY DEVICE MARKET,2021-2031
FIGURE 04. TOP INVESTMENT POCKETS IN HYSTERECTOMY DEVICE MARKET (2022-2031)
FIGURE 05. MODERATE THREAT OF SUBSTITUTES
FIGURE 06. MODERATE INTENSITY OF RIVALRY
FIGURE 07. HIGH BARGAINING POWER OF BUYERS
FIGURE 08. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. GLOBAL HYSTERECTOMY DEVICE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY COUNTRY 2021 AND 2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY COUNTRY 2021 AND 2031(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY COUNTRY 2021 AND 2031(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 16. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY COUNTRY 2021 AND 2031(%)
FIGURE 21. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 25. HYSTERECTOMY DEVICE MARKET BY REGION, 2021
FIGURE 26. U.S. HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 27. CANADA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 28. MEXICO HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 29. GERMANY HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 30. FRANCE HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 31. UK HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 32. ITALY HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 33. SPAIN HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 34. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 35. JAPAN HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 36. CHINA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 37. INDIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 38. AUSTRALIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 39. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 40. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 41. BRAZIL HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 42. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 43. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 44. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)
FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 48. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 49. COMPETITIVE DASHBOARD
FIGURE 50. COMPETITIVE HEATMAP: HYSTERECTOMY DEVICE MARKET
FIGURE 51. TOP PLAYER POSITIONING, 2021
FIGURE 52. CONMED CORPORATION.: NET SALES, 2020-2022 ($MILLION)
FIGURE 53. CONMED CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 54. CONMED CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 55. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
FIGURE 56. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 57. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 58. COOPER COMPANIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 59. COOPER COMPANIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 60. B. BRAUN MELSUNGEN AG: NET SALES, 2020-2022 ($MILLION)
FIGURE 61. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 62. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 63. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 64. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 65. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings